Contact urticaria syndrome from sorbitan sesquioleate in a corticosteroid ointment.
Hardy
M
M
Dermatology Department, Kaiser Permanente Medical Center, Hayward, CA 94545, USA.
Maibach
H I
HI
D000287:Administration, Topical; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology; D005260:Female; D005938:Glucocorticoids; D006229:Hand Dermatoses / Q000139:chemically induced*; D006601:Hexoses / Q000009:adverse effects*; D006801:Humans; D013501:Surface-Active Agents / Q000009:adverse effects*; D014581:Urticaria / Q000139:chemically induced*
D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D006601:Hexoses; D013501:Surface-Active Agents; C058854:sorbitan sesquioleate